The need for a refined understanding of CYP2D6 in second-generation antipsychotic outcomes in children and adolescents.
Katelyn M RossowSamuel E VaughnJeffrey A MillsSara L Van DriestLaura B RamseyPublished in: Pharmacogenomics (2021)
Tweetable abstract High-quality studies examining the influence of CYP2D6 on the exposure and tolerability of antipsychotics in youth are needed to mitigate the limitations of prior studies.